Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Headquarters
Ul. Ilzecka 24
Warsaw; Mazowieckie; Map
Postal Code: 02-135
Tel: +48 (22) 237, +48 (22) 237, +48 (22) 237
Fax: +48 (22) 237
Email: @its.jnj.com, consumerPL@its.jnj.com, mediakontakt@its.jnj.com
Website: http://www.jnjpoland.pl

Full name: Johnson & Johnson Poland Sp. z o.o.

Status: Non-Listed
Legal Form: Limited Liability Company
Operational Status: Operational
EMISid: 2007510
PL DUNS: 422187467
NIP: 1130020467
KRS: 0000032278
REGON: 006934330
Incorporation Date: 2001

Main Activities

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers

Company Description

Johnson & Johnson Poland Sp. z o.o. is a wholesaler of cosmetics, OTC drugs, medical equipment and other medical products.

More

Basic Information

Total Employees:
()
Registered Capital:
()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Export-Import

2016: Imports Thousands
Import connections ('000)

United Kingdom
Ireland
Netherlands
Belgium
Taiwan
South Korea
Turkey
Japan
Finland
Germany
China
Sweden
Italy
Switzerland
Mexico
Brazil
Thailand
Israel
United States
France
2016: Exports Thousands
Export connections ('000)

Finland
Belgium
United States
Lithuania
Italy

Key Executives

Management Board Member
More

Ownership Details

Johnson And Johnson Health Care System Inc (United States)
100%

Key Stats

Select Items to chart them. 2014 Q1
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 698,934
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Individual

Financials

Competitors - Poland

PLN | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2013
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest